CA2998867A1 - Dna binding agents with a minor groove binding tail - Google Patents

Dna binding agents with a minor groove binding tail

Info

Publication number
CA2998867A1
CA2998867A1 CA2998867A CA2998867A CA2998867A1 CA 2998867 A1 CA2998867 A1 CA 2998867A1 CA 2998867 A CA2998867 A CA 2998867A CA 2998867 A CA2998867 A CA 2998867A CA 2998867 A1 CA2998867 A1 CA 2998867A1
Authority
CA
Canada
Prior art keywords
compound
substituted
cancer
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2998867A
Other languages
English (en)
French (fr)
Inventor
Waldemar Priebe
Liwei Guo
Arkadiusz Kazimierski
Izabela Fokt
Charles Conrad (Deceased)
Timothy Madden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of CA2998867A1 publication Critical patent/CA2998867A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/62—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with more than three condensed rings
    • C07C13/66—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with more than three condensed rings the condensed ring system contains only four rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
CA2998867A 2015-09-16 2016-09-16 Dna binding agents with a minor groove binding tail Pending CA2998867A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562219380P 2015-09-16 2015-09-16
US62/219,380 2015-09-16
PCT/US2016/052144 WO2017049091A1 (en) 2015-09-16 2016-09-16 Dna binding agents with a minor groove binding tail

Publications (1)

Publication Number Publication Date
CA2998867A1 true CA2998867A1 (en) 2017-03-23

Family

ID=58289623

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2998867A Pending CA2998867A1 (en) 2015-09-16 2016-09-16 Dna binding agents with a minor groove binding tail

Country Status (8)

Country Link
US (1) US10358439B2 (enExample)
EP (1) EP3350145B1 (enExample)
JP (1) JP6966428B2 (enExample)
CN (1) CN108368006B (enExample)
AU (1) AU2016323777B2 (enExample)
CA (1) CA2998867A1 (enExample)
PL (1) PL3350145T3 (enExample)
WO (1) WO2017049091A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4433039A4 (en) * 2021-11-17 2025-10-29 Univ Texas WATER-SOLUBLE SALTS OF DNA-BINDING AGENTS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196127A (en) * 1978-06-01 1980-04-01 Research Corporation Anthracyclines
US4288608A (en) * 1978-06-01 1981-09-08 Research Corporation Synthesis of anthracyclines
ZA814722B (en) * 1980-07-18 1982-07-28 Hoffmann La Roche Novel anthracycline glycosides
CA1174669A (en) * 1980-07-18 1984-09-18 Michael J. Broadhurst Anthracycline glycosides
EP0971716A1 (en) * 1996-03-22 2000-01-19 Waldemar Priebe Bis-anthracyclines with high activity against doxorubicin resistant tumors
GB9812937D0 (en) * 1998-06-16 1998-08-12 Btg Int Ltd Compounds
WO2000056267A2 (en) 1999-03-19 2000-09-28 Waldemar Priebe Methods and compositions for the manufacture of c-3' and c-4' anthracycline antibiotics
WO2003072058A2 (en) 2002-02-27 2003-09-04 The Government Of The United States Of America, Representated By The Secretary, Deparment Of Health And Human Services Dna-binding polyamide drug conjugates
KR101186210B1 (ko) * 2002-12-03 2012-10-08 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 혈뇌장벽을 통과하는 물질 수송용 인공 저밀도 지단백질 운반체
SE0401066D0 (sv) * 2004-04-22 2004-04-22 Stefan Sjoeberg Chemical Derivatives
PL380561A1 (pl) 2006-09-05 2008-03-17 Szeja Wiesław Prochem Szeja Sposób otrzymywania pochodnych antracyklin
JP2012520298A (ja) * 2009-03-12 2012-09-06 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド Ｇａｂａに結合したアントラサイクリン−脂質複合体

Also Published As

Publication number Publication date
AU2016323777B2 (en) 2021-05-13
CN108368006A (zh) 2018-08-03
US10358439B2 (en) 2019-07-23
PL3350145T3 (pl) 2021-05-04
CN108368006B (zh) 2023-03-07
WO2017049091A1 (en) 2017-03-23
JP2018527372A (ja) 2018-09-20
US20180251454A1 (en) 2018-09-06
EP3350145A4 (en) 2019-03-27
EP3350145A1 (en) 2018-07-25
JP6966428B2 (ja) 2021-11-17
AU2016323777A1 (en) 2018-04-12
EP3350145B1 (en) 2020-09-16

Similar Documents

Publication Publication Date Title
AU2023226641A1 (en) Compositions for the delivery of trna as nanoparticles and methods of use therewith
JP7015856B2 (ja) がん治療のための組成物及び方法
WO2020205409A1 (en) Ionic liquids for drug delivery
CA3007988A1 (en) Substituted benzimidazolium, pyrido-imidazolium, or pyrazino-imidazolium compounds as chemotherapeutics
EP3303286B1 (en) Compounds that bind to rela of nf-kb for use in treating cancer
WO2019227040A1 (en) Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases
AU2018246138A1 (en) Compositions and method of treating cancer
CN107072970A (zh) 用于治疗癌症和其他增殖性疾病的新的辣椒平类似物
US10358439B2 (en) DNA binding agents with a minor groove binding tail
WO2017106624A1 (en) Napthoquinones, pro-drugs, and methods of use thereof
US20250009727A1 (en) Water-soluble salts of dna binding agents
US20160185745A1 (en) Analogs of vinaxanthone and xanthofulvin, methods of synthesis, and methods of treatments thereof
WO2018067551A1 (en) Texaphyrin and antitumor antibiotic conjugates
JP7789725B2 (ja) ナノ粒子としてのｔＲＮＡ送達用組成物およびその使用方法
HK1259495A1 (en) Dna binding agents with a minor groove binding tail
HK1259495B (en) Dna binding agents with a minor groove binding tail
US12054470B2 (en) Photoswitchable dibenzothienylmethyl triphenylphosphonium derivatives and methods of treating cancer therewith
JP7428642B2 (ja) 過剰増殖性疾患を処置するためのコーヒー酸誘導体
CN117486761A (zh) 一种含芳基的氯乙基亚硝基脲类化合物及其制备方法和应用
BR122024025919B1 (pt) Composição que compreende um composto de entrega aminolipídico, composição farmacêutica compreendendo a mesma e uso da composição para tratamento de uma doença genética
HK1190069A (en) Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
WO2017034893A1 (en) Novel polygodial analogs for the treatment of cancer and other proliferative diseases

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914

EEER Examination request

Effective date: 20210914